Drug Profile
C 013
Latest Information Update: 20 Mar 2019
Price :
$50
*
At a glance
- Originator Curatis
- Class Antimigraines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Tension type headache
Most Recent Events
- 20 Mar 2019 Discontinued - Phase-II for Tension type headache in Switzerland (unspecified route)
- 23 Feb 2016 Phase-II clinical trials in Tension headache in Switzerland (unspecified route)